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ABSTRACT
T-cells retain cell-type-specific programming for IL-2
inducibility through many rounds of division without
being stimulated to transcribe the locus. To under-
stand the layering of controls needed to poise this
gene heritably for activation, we have used chromatin
immunoprecipitation to map histone modifications
across the murine IL2 locus, from 10.2 through
+0.25 kb, in induction-competent and incompetent
cells. In highly inducible EL4 T-lineage cells, stimula-
tion with PMA/A23187 induced strong acetylation of
histone H3 and H4, in parallel with transcriptional
activation, from 4.6 through +0.25 kb. However,
dimethylation of histone H3/K4 was already fully
elevated across the same restricted domain before
stimulation, with little change after stimulation. RNA
polymerase II binding, in contrast, was only found at
the known promoter region after stimulation. Similar
patterns of histone modifications were seen also in
normal IL-2-inducible T-lineage cells. However,
neither acetylated histone H3, H4 nor dimethylated
histone H3/K4 marking was detected, with or with-
out stimulation, in expression-incompetent cells
(NIH/3T3 or Scid.adh). These results identify a dis-
crete new domain of IL2 regulatory sequence marked
by dimethylated histone H3/K4 in expression-
permissive T-cells even when they are not transcrib-
ing IL2, setting boundaries for histone H3 and H4
acetylation when the IL2 gene is transcriptionally
activated.
INTRODUCTION
Mammalian development makes extensive use of stem-
like cells for different tissues, in which a specific range of
developmental potentials is programmed for future use
without being overtly expressed, a condition that can persist
for long periods of time (1). Epigenetic chromatin marking
could be involved in establishment and long-term maintenance
of the latent gene expression capabilities that must exist in
these cells. However, for most mammalian systems of devel-
opmental gene regulation in which chromatin configurations
have been studied closely, changes in potential for expression
of a gene have been tightly linked to changes in actual tran-
scriptional activation of that gene, making the mechanisms
difficult to disentangle. Chromatin modifications, such as acet-
ylation of histones H3 and H4, and methylation of H3 on Lys-4
(H3/K4), are known to be correlated with ‘open’ chromatin,
but in most cases studied this is also transcriptionally active
chromatin [reviewed in (2,3)]. Epigenetic marking strictly
correlated with latent activity has been analyzed only rarely
(4–6). Here, we propose that the murine IL2 gene can shed light
on this more general problem in developmental molecular
biology.
IL-2 is one of the important cytokines produced by mature
T-cells in response to antigenic stimuli. IL2 gene regulation is
subject to dual control, since it acutely depends on combinat-
orial signaling through particular combinations of pathways,
and can only be activated in a very limited spectrum of cell
types [reviewed in (7–9)]. Although strongly induced by com-
binations of Ca2+, Ras/MAP kinase and costimulatory signals,
IL-2 transcription is transient and returns to an ‘off’ state in
expression-competent cells between bouts of stimulation.
For the most part, competence to express IL2 is restricted to
T-lymphoid cells and a few other hematopoietic cell types, and
its expression is observed in certain immature stages (10,11)
as well as in the antigen responses of mature T-cells. The
regulatory basis for the activation dependence of IL2 gene
expression in T-cells is well-understood, with key roles for
NF-AT, NF-kB/c-Rel and AP-1 factors interacting with
constitutive regulators such as Oct-1 in a 300 bp promoter-
proximal region [reviewed in (7,9,12,13)]. Additional regu-
lators such as HMG box factors and the Ets factor
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GABPa may also play a role, through highly conserved
sites just 100–200 bp further upstream (14,15). The binding
of these factors in response to activation is correlated with
changes in DNA methylation at a series of sites extending
from the promoter to about 800 bp (16). However, the
basis for IL2 cell-type specificity is still obscure, since all of
the known transcription factors used for its induction are
expressed broadly in many cell types that cannot express
the gene. Meanwhile, the great majority of naı¨ve T-cells
retain the potential to activate IL2 expression even after
long periods when the gene is transcriptionally silent.
The cell-type-specific regulation of IL-2 presents one of
the clearest known cases of dissociation between develop-
mentally programmed competence to express a gene, and
actual expression of that gene for the great majority of a cell’s
lifetime.
Transgenic studies have shown that the highly conserved
600 bp region that contains the proximal promoter-enhancer is
not enough for IL2 regulatory sequence activity in transgenic
mice (17,18), raising the possibility that additional positive
regulatory functions may be encoded elsewhere. Addition of
less-characterized sequences to 2.0 to 2.7 kb (with respect
to the IL2 transcriptional start site) permit correct expression
in a fraction of transgenic founder lines (19,20). While ectopic
expression of these constructs is rare, the locus appears
to require additional sequences to counteract silencing.
Experiments with hybrid regulatory sequence constructs
show that one of the functions needed can be supplied by
the locus control region of the human CD2 gene (21). We
have therefore hypothesized that the basis of cell-type
specificity might reside in a discrete regulatory function
that controls IL2 chromatin accessibility (7,14). If so, then
the sequences through which this effect is mediated could
be expected to improve the frequency and efficiency of
expression of IL2 regulatory sequence transgenes if these
sequences were included.
Previously, we reported that a GFP transgene driven with
8.4 kb of IL2 50-flanking sequence (8.4 kb IL2-GFP) displayed
efficient, lineage-specific expression in transgenic mice, much
improved in frequency and fidelity as compared to a 2.0 kb
IL2-GFP transgene (20). Thus, the additional 6.4 kb upstream
sequence contains important regulatory regions for conferr-
ing accessibility to induction on the IL2 gene. Here, we use
analyses of the chromatin structure in these IL2 upstream
regions to investigate the nature of the regulatory function
that they confer.
To analyze features of the distal sequence, we performed
chromatin immunoprecipitation (ChIP) assays to define the
nature and extent of any associated histone modifications.
Here, we report significant levels of histone acetylation
(AcH3, AcH4) and histone H3 lys-4 dimethylation (diMeH3/
K4) in a discrete region from 4.6 kb through the promoter
and first exon of the IL2 gene in IL-2 producing T-cells.
Whereas acetylation was seen only in cells transcribing the
gene in response to stimulation, diMeH3/K4 is maintained at a
high level across the same region in cells competent to express
IL2, even before stimulation. These results indicate the pres-
ence of transcriptionally permissive state which is marked
by diMeH3/K4 without histone acetylation over a discrete
50-flanking domain of the IL2 gene, and which is restricted
to competent IL-2-inducible cells.
MATERIALS AND METHODS
Cell culture and stimulations
EL4.F4 cells (22,23), Scid.adh cells (24), NIH/3T3 cells and
splenocytes were cultured in RPMI 1640 medium supplemen-
ted with 10% fetal bovine serum (HyClone, South Logan, UT),
50 mM 2-mercaptoethanol, 0.1 mM MEM non-essential
amino acids (Invitrogen, Carlsbad, CA), 10 mM HEPES,
1 mM sodium pyruvate (Sigma–Aldrich, St Louis, MO),
2 mM L-glutamine and penicillin/streptomycin.
Cells were stimulated for 3 h with 10 nM PMA and 180 nM
A23187 (Sigma–Aldrich). Cell concentrations were 106 cells/
ml of non-adherent cells and were semi-confluent of adherent
cells. For stimulations of TCR-negative SCID thymocytes,
IL-1a (10 ng/ml; Biosource, Camarillo, CA) was also required
in the stimulation cocktail (25–27), but IL-1a has no effect on
responses of CD4+ CD8+ cortical thymocytes, as previously
described (28).
Purification of B220 splenocytes and thymocytes
from SCID and MHC-deficient mice
Red-blood cell depleted splenocytes from C57BL/6 mice were
stained with biotin-conjugated anti-B220 Ab (Immunotech,
Marseille, France), and then incubated with streptavidin-
conjugated MACS microbeads (Miltenyi Biotech, Auburn,
CA). Cells were passed through MACS columns to remove
B220+ cells. Purity of separated cells was determined by stain-
ing with FITC-conjugated anti-B220 Ab (BD PharMingen,
San Diego, CA). Thymocytes were prepared by mincing the
tissue followed by filtration through a wire mesh.
Chromatin immunoprecipitation assay
Antibodies for ChIP assays were purchased from the following
companies. Anti-acetyl-histone H3 (06-599), anti-acetyl-
histone H4 (06-866) and anti-dimethyl-histone H3 (Lys-4)
(07-030) were from Upstate Biotechnology, Inc. (Lake Placid,
NY). Anti-Pol II (N-20) (sc-899) and normal rabbit IgG
(sc-2027) were from Santa Cruz Biotechnology (Santa
Cruz, CA).
ChIP assays were performed by the protocol of Upstate
Biotechnology with modifications. Briefly, samples of
2 · 107 cells were subjected to protein–DNA crosslinking
with formaldehyde at a final concentration of 0.4% for
10 min at room temperature. Cells were lysed in 1 ml of
lysis buffer (1% SDS, 10 mM EDTA and 50 mM Tris–
HCl, pH 8.0) and DNA was sheared by sonication (Labsonic
1510, B. Braun, Melsungen, Germany) at 100 W for 1 min, to
lengths between 200 and 1000 bp.
One hundred microliters of sonicated sample was kept as
an input sample, and the remainder was diluted with 8.1 ml of
dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris–HCl, pH 8.0 and 167 mM NaCl).
Diluted samples were precleared with 100 ml of salmon
sperm DNA/protein A agarose (Upstate Biotechnology) for
1 h, then divided into three tubes (3 ml each).
Ten micrograms of antibodies were added to each tube and
incubated for 3–4 h. After that, 60 ml of salmon sperm DNA/
protein A agarose was added and incubated overnight at
4C. Agarose was washed once with 1 ml of low salt buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl,
Nucleic Acids Research, 2005, Vol. 33, No. 10 3201
pH 8.0 and 150 mM NaCl), high salt buffer (0.1% SDS,
1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8.0
and 500 mM NaCl), LiCl buffer (0.25 M LiCl, 1% NP-40,
1% deoxycholate and 1 mM EDTA), and twice with TE buffer
(pH 8.0). Immune complexes were eluted twice with 250 ml of
elution buffer (1% SDS and 0.1 M NaHCO3). Protein–DNA
crosslinking was reversed by incubation at 65C for 4 h with
0.2 M NaCl, and then protein was digested at 45C for 1 h
in the presence of 10 mM EDTA (pH 8.0), 40 mM Tris–
HCl (pH 6.5) and 40 mM proteinase K. The DNA was pur-
ified by phenol–chloroform extraction followed by ethanol
precipitation.
Quantitative PCR analysis
Quantitations of chromatin immune precipitates were per-
formed by real-time PCR using the ABI Prism 7700 Sequence
Detection System (PE Applied Biosystems, Foster City, CA).
Primers were designed by the Primer3 website (http://frodo.
wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) (29) to amp-
lify 100–250 bp amplicons. PCR analyses were performed
in 25 or 30 ml reactions with SYBR Green (PE Applied Biosys-
tems). All primer sets used gave no signal (CT > 40) in control
reactions without template. Dissociation curve analyses
showed that single products with expected Tm values were
generated by each primer set. A second peak of lower Tm was
detected only in products of one primer set (8.9 to 8.7),
or as a shoulder in products of one other set (3.2 to 3.0).
Standard curves were determined for each primer set by
dilution of input DNA in a 0.1–100 ng range, and only primer
sets yielding slopes close to the theoretical values for 1.9- to
2.0-fold amplification per cycle were used. The amounts
of each sequence in the input and precipitated DNA were
calculated from the cycle thresholds (CT) for each primer
set by using the standard curves. Relative units recovered
for each primer set were determined by dividing the calculated
amounts of precipitated sequence by the amount of that
sequence in the input DNA. Due to lower cell recovery of
primary thymocytes, results in Figure 7 were further normal-
ized by the results of the S16 ribosomal protein gene.
RNA purification and real-time quantitative RT–PCR
Total RNA was extracted from the cells by RNAzol (Leedo
Medical, Houston, TX) following the manufacturer’s instruc-
tions. One microgram of RNA was treated with RNase-free
DNase I (Boehringer Mannheim, Mannheim, Germany) for
30 min at 37C. After that, DNase was inactivated by the
incubation for 5 min at 75C. Then, first-strand synthesis reac-
tions were performed with Super-script II reverse transcriptase
(Invitrogen, Carlsbad, CA) and 500 ng oligo dT primers
(Pharmacia, Uppsala, Sweden) following standard protocols.
Real-time PCR was performed by using ABI Prism 7700
Sequence Detection System (PE Applied Biosystems).
Taqman probes and primers for murine IL-2 (FAM labeled)
and GAPDH (VIC labeled) were purchased from PE Applied
Biosystems. To normalize the samples, control GAPDH
CT values were subtracted from IL-2 CT values of each
sample (DCT). Then, DCT of the unstimulated NIH/3T3 sample
(reference sample) was subtracted from DCT of each sample
(DDCT). Relative levels of IL-2 mRNA were calculated
as 2DDCT.
RESULTS
Stimulation with PMA/A23187 induces histone
acetylation at the IL2 locus in IL-2 producing cells only
Several lines of evidence suggested that regulatory elements
important for cell-type-specific accessibility of the IL2 gene
might reside on the 50 side of the well-characterized promoter-
enhancer region. First, a series of T-cell-specific DNase I
hypersensitive sites were found between 10 and 2 kb
from the transcriptional start site of the IL2 gene, including
a cluster of cell-type-specific sites from about 2.8 to 4.5 kb
which were hypersensitive even in resting cells (20). Second,
a GFP reporter transgene controlled by an extended 8.4 kb
upstream region of the IL2 gene, which includes most of the
new hypersensitive sites, showed more efficient, lineage-
specific expression in transgenic mice than a GFP transgene
controlled by a 2.0 kb IL2 regulatory region, which does not
include any of the new hypersensitive sites (20). Most
recently, comparative genomics have made it possible to
identify three islands of mouse–human sequence similarity
upstream of the IL2 gene, as indicated in Figure 1 (for full
three-way alignment of murine, human and rat sequences,
see Supplementary Figure 1). Two of these islands lie within
the region included in the 8.4 kb IL2 promoter transgene and
one lies just beyond it.
Although indicating some functional significance for the
region between 2.0 and 8.4 kb, the transgenesis results
did not determine whether the sequences in this region act
as auxiliary stimulation-dependent enhancers, amplifying the
response upon induction, or whether they mark the locus stably
as accessible to induction by a separate mechanism uncoupled
from transcription. To determine which regions of the exten-
ded IL2 upstream region might participate in control of IL-2
expression, we used ChIP with quantitative real-time PCR
quantitation. Although regions enriched for simple-sequence
repeats needed to be excluded from analysis, we designed 17
primer sets to amplify segments from the first transcribed exon
up to 10 kb of the IL2 gene (Figure 1 and Table 1), including
amplicons bridging all three of the conserved regions. To
correlate chromatin structure with competence to express
IL-2, the murine thymoma cell line EL4, the immature
pro T-cell line Scid.adh and the non-hematopoietic cell line
NIH/3T3 were subjected to ChIP assay with or without
PMA/A23187 stimulation. Of these, EL4 is the only one which
expresses IL-2 in response to stimulation (Figure 2A). How-
ever, in unstimulated EL4 cells, the IL2 gene is virtually
silent, with levels of RNA >105-fold lower than after 3 h of
stimulation (note log scales in Figure 2).
In resting EL4 cells, acetylation of histones H3 and H4 was
not substantially elevated across the IL2 locus, and the recov-
ery of all IL2 flanking sequences was low compared to the
positive control. However, acetylation was greatly increased
after 3 h of stimulation with PMA/A23187, in a defined inter-
val across the sequences from 4.6 through +0.25 kb. By this
time point, specific transcription factor occupancy of target
sites in the enhancer is already maximal, as we have reported
previously (30). The acetylated region included two islands
of mouse/rat/human conserved sequence, at about 2.2 and
at about 3.9 kb, but excluded the third, more distal conserved
region at about 8.6 kb and all other regions tested out to
10.2 kb.
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Unexpectedly, within the region from 4.6 through
+0.25 kb, the sequence that was least enriched in acetylated
H3 and H4 immune precipitates after stimulation was
the amplicon from the IL2 proximal promoter region
itself (0.24 to0.05 kb) (Figure 3A; top). Since the proximal
promoter is known to be a core region for IL-2 transcription
factor binding which undergoes dramatic changes in
nuclease accessibility upon stimulation (14,30–34), the regu-
latory protein complexes that are assembled there upon induc-
tion might exclude nucleosomes or mask epitopes of
acetylated histone. A similar result has been reported for active
promoters in the b-globin and prostate-specific antigen loci
(6,35). In accordance with our results, a recent report has
demonstrated directly that stimulation causes specific loss
of histone protein from the proximal promoter region of the
IL2 gene (36).
Acetylation at the IL2 locus appears to be regulated norm-
ally by an equilibrium between histone acetyltransferase and
histone deacetylase (HDAC) activities, because exposure of
the cells to HDAC inhibitor trichostatin A increases acetyla-
tion of H3 and especially H4, even in the absence of stimu-
lation (Supplementary Figure 2A). This increased acetylation
is not associated with transcriptional induction; in fact, trichos-
tatin A decreases the induction of IL-2 in response to
stimulation under the conditions used here (37) (Supplement-
ary Figure 2B). Even so, most increased acetylation induced
by trichostatin A is seen in the region between about5 kb and
the promoter region, where the stimulation-inducible acetyla-
tion occurs (Supplementary Figure 2A).
The IL2-nonproducing cell lines, Scid.adh and NIH/3T3,
maintained very low levels of acetylation of the IL2 gene
flanking sequences with no increase upon stimulation
(Figure 3A; middle and bottom); however, the acetylation
of a sequence from the S16 ribosomal protein promoter was
comparable between all these three cell lines (Figure 3B).
Controls without antibody or with normal IgG precipitation
did not detectably precipitate IL2 sequences in any of these
cell lines (Supplementary Figure 3). Thus, there is a specific
IL2 upstream region extending to 4.6 kb, i.e. >4 kb beyond
the well-characterized proximal promoter-enhancer, which is
subject to histone acetylation only upon stimulation and only
in IL-2 induction-competent cells.
Dimethylation of histone H3/K4 at the IL2 upstream
region before stimulation in EL4 cells
To assess whether there is any other kind of modification at
the IL2 locus that might mark it as accessible, we monitored
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Figure 1. Diagrams of DNase hypersensitive sites and primer positions on the IL2 locus. DNase hypersensitive sites in stimulated and unstimulated purified splenic
T-cells are shown by arrows (#). Regions of high homology with an upstream sequence in the human IL2 gene were determined by Blast search (H). Putative matrix
attachment region (MAR) and a region of high homology with an intronic sequence in the Bruton’s thymidine kinase gene (Btk) are also indicated. For full alignment
of these murine IL2 sequences with human and rat orthologues using FamilyRelations and SeqComp software (46), see Supplementary Figure 1. Bottom: the
functional importance of these sequences is demonstrated by the distinct behavior of IL2 regulatory sequence transgene constructs previously reported by this group
(20). The sequences to8.4 kb, but not the sequences to2.0 kb, are sufficient to direct IL2-like expression of the reporter gene in a high frequency of independent
integration sites (20).
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dimethylation of histone H3/K4, which is also associated
with active chromatin and often accompanies acetylation
(6,38–41). Like AcH3 and AcH4, diMeH3/K4 was highly
associated with sequences from 4.6 through +0.25 kb in
EL4 cells after stimulation (Figure 4A; top). However, unlike
acetylation, a significant level of diMeH3/K4 was observed
from 4.6 through +0.25 kb before stimulation as well, com-
parable to its level after stimulation. In unstimulated EL4 cells,
this modification could also be seen to extend through the
proximal promoter (0.24 to 0.05 kb), although it appeared
somewhat decreased after stimulation. In the Scid.adh and
NIH/3T3 cells, in contrast, which cannot express IL-2, no
association of diMeH3/K4 with the IL2 gene was observed,
with or without stimulation (Figure 4A; middle and bottom).
These differences were specific to the IL2 gene, because
diMeH3/K4 modification of chromatin associated with the
S16 ribosomal protein promoter was comparable in the
three cell lines (Figure 4B).
RNA polymerase II is not bound to the distal region
of the IL2 gene
Both AcH3, H4 and diMeH3/K4 modifications extend >4 kb
from the known promoter-enhancer of the IL2 gene. We con-
sidered possible explanations for the relatively sharp 50 border
and the broad extension of the modified region all the way
through the promoter-enhancer. In some cases, pol II itself is
recruited to a distal regulatory region (42), from which it can
spread acetylated histone in a 50 to 30 polar fashion as it moves
along the gene [e.g. (41,43)]. Therefore, we analyzed pol II
binding on the IL2 gene in EL4 cells by ChIP assay. As
expected, pol II immune precipitation of stimulated EL4
cell samples enriched for promoter proximal sequences
(amplified with primers from 0.24 to 0.05 kb), with further
enrichment of sequences immediately downstream of the tran-
scriptional start site (+0.06 to +0.25 kb). Pol II recruitment was
correlated with transcriptional activation, as little or no enrich-
ment was seen in samples from unstimulated cells. However,
even in stimulated EL4 cells, only minimal binding was found
from 4.6 through +0.25 kb, or in more distal 50 sequences
(<20% of promoter level) (Figure 5). Thus, no evidence for
specific pol II recruitment was found in any of the upstream
regions examined.
 
 
Figure 2. Quantitative RT–PCR of IL-2 mRNA induction in different cell
types. RNA was extracted from the indicated cell types, either unstimulated
or stimulated with PMA/A23187 for 3 h. IL-2 mRNA levels were determined in
the samples by real-time PCR following reverse transcription, and normalized
to equal GAPDH levels. Units of IL-2 mRNA expression were then calculated
as 2DDCT relative to an unstimulated NIH/3T3 sample (20 = 1). (A) Cell lines
NIH/3T3 (fibroblasts, nonhematopoietic), Scid.adh (pro-T-like thymic lym-
phoma), and EL4 (mature T-cell thymic lymphoma), compared with primary
B220 splenic lymphocytes (mature T-cells). Levels of IL-2 in stimulated EL-4
and B220 splenic T cell samples are within 2- to 3-fold of the levels of GAPDH
(data not shown). (B) Primary immature pro-T cells from SCID thymus,
compared with primary CD4+ CD8+ TCR-low cortical thymocytes from
MHC-deficient thymus. For SCID thymocytes, stimulation was only for 2 h,
in the presence or absence of IL-1a as indicated. Levels of IL-2 in maximally
stimulated SCID thymocytes are 1% of the level of GAPDH. Note that all
results are displayed on a log scale. ND = not determined.
Table 1. Sequences of the primers
10.2 to 10.0 50-ACCTTGGGAGCTGAAATCCT
50-TTTTGAGGGATCGCTAATGG
8.9 to 8.7 50-TGTTTTAGCCCACAAGATTT
50-GAGTGGCAATAGAAAAATGC
8.3 to 8.1 50-TGACAATGCTGGCTTCTGAC
50-CAAGCAAAACGATCCAAGAG
7.5 to 7.4 50-TACCTATGGAAGAAGTTACA
50-AATCTTGTTGGCATCTGCAA
7.0 to 6.8 50-GGAGGGATAGGGGATTTTCA
50-TGGTTCTTACAAAACCACTGAGC
6.6 to 6.5 50-GTGCTCTTAAGTGATCAGTA
50-GAAGTGCATATGTGTATGTA
6.0 to 5.8 50-TTAGGCCACCCATGGTACTC
50-ACAAAGAGGCCCATTCTCCT
4.6 to 4.4 50-TGGGCTAGATTTCCATAAGAACA
50-TGTCAAAAGCACCCTTTTCC
4.0 to 3.8 50-CCACCACACCCAGCTTTTAT
50-CCTTTCAAGCCCTGAGGATT
3.8 to 3.6 50-CTCAGGGCTTGAAAGGACAG
50-TGCCTCAGGACATTCCTACA
3.2 to 3.0 50-CAGATGGGACGAGAGAGAGG
50-ACAGCTGACTCCGACTTGGT
2.3 to 2.1 50-AGCCCATGAGGACATCAAAG
50-CGTGAGGGGCATCTACCTAA
1.6 to 1.4 50-ACCCACAGTGTGCATGTAGC
50-AGCCTCACCACACACCTACC
1.2 to 1.1 50-CACGGAGGATAAGGAATCCA
50-GCCTTTACCACTGAGCCATC
0.81 to 0.68 50-CACGCACATGCACATACTCA
50-TCTCAGGAAGGGTTGCATCT
0.24 to 0.05 50-GCCACCTAAGTGTGGGCTAA
50-ATATGGGGGTGTCACGATGT
+0.06 to 0.25 50-CTCGCATCCTGTGTCACATT
50-GGATGGCTGTGCACTTACCT
S16 ribosomal
protein promoter
50-ATTCACACGTCCCCTCTCAG
50-ATAGCTCCGAGCACAAGCAC
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Histone modifications at the IL2 locus in primary
T-cells resemble those in EL4 cells
To determine whether the distinctive patterns of chromatin
modifications found in EL4 cells could be relevant to normal
T-cell control of IL-2 expression, we examined three
developmentally distinct populations of primary T-lineage
cells: mature, peripheral splenic T-cells; cortical TCRlow
CD4+ CD8+ thymocytes (>95% of cells in MHC-deficient
thymus); and immature TCR SCID thymocytes. As previ-
ously reported (10,25,44), both mature peripheral T-cells
and SCID thymocytes can be stimulated to express IL-2
(Figure 2A, ‘B220-’; Figure 2B, ‘scid thy’), but the cortical
thymocytes, although developmentally intermediate, cannot
(Figure 2B, ‘MHC/’).
ChIP assays for AcH3 and diMeH3/K4 were performed
on samples of stimulated or unstimulated peripheral T-cells,
which were highly enriched from C57BL/6 mouse spleens by
A
B
   
   
 
    
 
                    
  
Figure 3. Histone acetylation pattern of the IL-2 gene. (A) Acetylated histone H3 and H4 of the IL-2 gene were analyzed with quantitative ChIP assay. Results of EL4,
Scid.adh and NIH/3T3 cells are shown. (B) Acetylated histone H3 and H4 on the promoter of S16 ribosomal protein. The results are shown as mean – SD of three
or four independent experiments. Open bars; unstimulated, filled bars; stimulated with PMA/A23187.
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magnetic bead depletion of B220+ cells, as shown in Figure 6A.
In these cells, AcH3 was increased from 4.6 kb through the
IL-2 promoter after stimulation, while diMeH3/K4 was high
from 4.6 kb to downstream both before and after stimulation
(Figure 6B, B220 cells). These patterns in stimulated and
unstimulated primary T-cells closely match those in EL4 cells.
The maximum increase of AcH3 upon stimulation in B220
cells was only 4- to 5-fold, as compared to >10-fold in EL4
cells (Figure 3A; top), but this may be attributed to known
quantitative differences between the frequencies of IL-2
induction in unstimulated primary T-cells and in EL4 cells
(Figure 2). The fraction of primary T-cells expressing IL-2
mRNA in a particular response is never as high as the fraction
of EL4 cells, which can approach 80% (E. V. Rothenberg,
unpublished data), whereas the background level of IL-2
mRNA expression in unstimulated B220 cells ex vivo is
often higher than that of unstimulated EL4 cells, possibly
due to a low frequency of cells that received some stimulation
in vivo already (45). Thus, these results indicate that chromatin
modification of the IL2 locus from 4.6 kb through the pro-
moter region may be a stable characteristic of normal mature
T-cells.
Dimethyl H3/K4 marking correlates with competence
to express in immature T-lineage cells
To determine how early in T-lineage development this chro-
matin modification might be detectable, SCID thymocytes
were analyzed. Although SCID thymocytes cannot rearrange
or express T-cell receptor genes and thus remain immature,
they are inducible for IL-2 expression (Figure 2B) (up to 20%
of the cells capable of expressing IL-2 mRNA in immediate
response to stimulation in C.B17-SCID) (26,27). In two inde-
pendent experiments, even without stimulation, SCID thymo-
cytes showed high association of diMeH3/K4 with the region
from 4.6 kb through the promoter region (Figure 7, top
graph). Thus, both immature and mature T-cells specifically
modify chromatin in a defined region upstream of the IL2
promoter.
The shared pattern of epigenetic marking in mature and very
immature populations could be strictly correlated with com-
petence to express IL-2, or it could be a lineage marker for all
normal T-lineage cells. To distinguish these possibilities, we
           
 
    
 
Figure 4. Dimethylated histone H3 at lys-4 is observed before stimulation in
EL4 cells. (A) ChIP analyses were performed for diMeH3/K4 on the IL2 locus
of EL4, Scid.adh and NIH/3T3 cells. DiMeH3/K4 on the promoter of S16
ribosomal protein is shown in (B). The results are shown as mean – SD of
three independent experiments. Open bars; unstimulated, filled bars; stimulated
with PMA/A23187.
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Figure 5. Binding of RNA polymerase II on the IL2 locus. ChIP analyses were
performed for pol II binding on the IL2 locus of EL4 cells. The results are shown
as mean – SD of three independent experiments. Open bars; unstimulated,
filled bars; stimulated with PMA/A23187.
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analyzed intermediate CD4+ CD8+ TCR-low thymocytes,
which constitute >95% of the cells in the thymus of major
histocompatibility complex-deficient mice (MHC/). These
cells are more advanced than SCID thymocytes development-
ally, but have lost or suspended all competence to express IL-2
(10,28,44). As shown in Figure 7 (bottom graph), these cells
show much lower levels of diMeH3/K4 modification over
the IL2 flanking sequences, relative to S16 positive control
sequences, than EL-4 cells, mature T-cells or SCID thymo-
cytes. The pattern is also flat, with little if any increase in
modification over the region from 4.6 kb to the promoter.
Thus, diMeH3/K4 modification over the region from 4.6 kb
to the IL2 promoter is not universal among all T-lineage cells,
but is tightly linked to the ability to express IL-2.
In summary, as shown in Figure 8, both diMeH3/K4 and
AcH3 types of modifications of the IL2 flanking sequences
are cell-type specific. Both are restricted to T-lineage cells
that are competent to express IL-2 and not found in fibroblasts
or T-lineage cells that lack this competence. However,
histone acetylation is tightly linked with the recruitment of
active transcription complexes to the IL2 promoter. Only
diMeH3/K4 marking is a stable differentiated characteristic
of these competent cells that is retained at the locus as long
as they retain their developmental state, in vivo and in vitro,
even in the absence of activating signals and in the com-
plete absence (<105 of the induced levels) of IL-2 mRNA
expression.
DISCUSSION
The basis for competence to induce transcription of the IL2
gene in particular cell types has long been obscure, in contrast
Figure 6. Pattern of acetylated histone H3 and dimethylated histone H3 at lys-4
at the IL2 locus in an enriched population of mature splenic T-cells. B220+ cells
were depleted from C57BL/6 mouse splenocytes by magnetic columns (A),
and the remaining B220 cells (T-enriched) were subjected to ChIP assay (B).
Two independent experiments were done with similar results. Open bars;
unstimulated, filled bars; stimulated with PMA/A23187.
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Figure 7. Dimethylated histone H3/K4 association with IL2 50-flanking region
is correlated with IL-2 inducibility in immature thymocytes: ChIP analysis
of the IL2 locus in thymocytes from SCID and MHC-deficient mice. Cells
from MHC-deficient mice, >95% CD4+ CD8+ TCR-low, were cultured with
or without PMA/A23187 for 3 h. Cells from SCID mice, >95% CD4 CD8
TCR-negative, were cultured with or without stimulation for 2 h, and IL-1awas
also added as indicated. To correct for differences in efficiency of immune
precipitation between these samples due to the extensive differences in cell
physiology, ChIP analysis results for diMeH3/K4 at the IL2 locus for each
sample were normalized by results at the S16 ribosomal protein locus. Two
independent experiments were done with similar results.
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to the detailed knowledge that has been accumulated about
the mechanism that actually triggers transcription of this locus
in competent cells. Previously, we showed that sequences of
the IL2 gene between2 kb and8.4 kb (extended 50-flanking
sequence) could be involved in such a function, since they
greatly enhance the likelihood of expression of an IL2
promoter-GFP transgene in the correct cells (20). The function
conferred was not defined, however, and the sequences
involved in the function were not mapped. Here, we report
that a particular segment of the extended 50-flanking sequence
is a site for epigenetic marking by histone H3/K4 dimethyla-
tion that occurs only in IL-2 expression-competent cells. This
modification is cell-type specific, tightly linked with com-
petence of the IL2 locus to be induced by stimulation,
and coincides with the region in which increased AcH3 and
AcH4 modifications occur when transcription is activated
(Figures 3, 4 and 6). However, this H3/K4 methylation is
uncoupled from detectable IL2 transcription, from pol II
binding, and from histone acetylation, and it persists independ-
ently of stimulation. Our data provide the first direct evidence
for the existence of a discrete, developmentally controlled
mechanism that may control cell-type-specific accessibility
of the IL2 locus, working through different sequences and
different trans-acting factors than those that activate trans-
cription of the gene in response to induction.
The relationship between H3/K4 methylation and IL-2
expression supports the model that sequences between
2 and 8.4 kb can have a discrete role in conferring cell-
type-specific accessibility on this gene that is separable from
any enhancer activity. Indeed, the 8.4 kb IL2 regulatory region
does not drive reporter gene expression any better than the
2.0 kb regulatory region, when tested in transient transfection
experiments (20). Two groups of DNase HS sites, centered
around different mouse/human homology blocks, suggest that
the upstream region may include two types of function.
The distal portion of the H3/K4 methylation-marked region,
from 4.6 to about 2.8 kb, includes the group of DNase I
hypersensitive sites which are most pronounced in resting, not
activated, T-cells. Activation of IL-2 transcription induces
the appearance of new DNase HS sites, including a cluster
around the mouse/human homology block from about 2.2 to
2.3 kb as well as in the promoter-proximal region (14,20).
This 2.2 kb region may indeed have cryptic enhancer-like
activity. However, activation if anything reduces the promin-
ence of the major DNase hypersensitive site around 4.5 kb
(20), at the distal boundary of the MeH3/K4 marked domain.
A clear inference would be that any transcription factors
binding to regulatory sites in the 2.8 to 4.6 kb upstream
region would be distinct from these stimulation-activated
transcription factors.
Identification of the critical regulatory elements in this inter-
val is impeded by the remarkably poor sequence conservation
between human and murine sequences beyond 2.3 kb in the
mouse sequence. When the human, mouse and rat IL2 flanking
sequences are aligned (46) (Supplementary Figure 1), the only
well-conserved sequence from 2.8 to 4.6 kb is a 64 bp
stretch at about 3.9 kb in the murine gene (in the human
gene, a LINE element insertion shifts this alignment further
upstream). This conserved element should thus provide a use-
ful point of departure for identification of the factors which
control the establishment or maintenance of the MeH3/K4
marked domain.
Only minimal histone modifications were seen further
upstream of 4.6 kb, with or without stimulation. It remains
to be seen whether known boundary-forming transcription
factors such as CCCTC-binding factor (CTCF) or the
bHLH-ZIP ‘Upstream Factor’ (USF) play a role in setting
these limits. Interestingly, there are several E-box motifs
which might bind USF between 8.0 and 8.4 kb, and a
predicted double binding site around 6.2 kb. A recent article
shows that USF binds to the chicken b-globin 50HS4 insulator,
where it protects the gene from chromosomal silencing by
recruitment of histone modification factors (47). It may
play a role to keep the IL2 gene accessible by the same mech-
anisms. Closer to the region where we see discontinuities in
IL2 chromatin structure, there is an unusually dense clustering
of seven CCCTC motifs between 4.5 and 5.3 kb from
the transcription start site. Although functional target sites
of CTCF can be difficult to predict based on sequence
alone (48), these sites will clearly be of interest for further
investigation.
The mechanism maintaining the MeH3/K4-marked IL2
50-flanking region in unstimulated cells is clearly distinct
from the highly coordinated assemblies of transcription fac-
tors, histone acetyltransferases and RNA pol II which are seen
associated with ‘open chromatin’ in other sites (42,43,49,50).
In the case of the IL2 gene, a stable pattern of H3/K4 methy-
lation appeared to be maintained even in the absence of any
substantial pol II binding to the region between 4.6 kb and
the promoter. The minimal level of binding that was seen
could be consistent with co-precipitation by interaction of
distal regulatory regions with the proximal promoter via
looping, rather than with direct binding. The IL2 gene thus
joins a small number of cases where diMeH3/K4 is associated
with accessibility to transcription before transcription itself is
induced. In some cases, this modification appears to demarcate
the boundaries of a region within which transcription and/or
DNA recombination can occur (40,51). Recently, a two-step
chromatin modification sequence, with diMeH3/K4 modifica-
tion preceding histone acetylation, was shown in a variety of
genes activated during hybridization between ES cells and
somatic cells (52). Even if this sequence is used for regulation
of many genes, the regulatory style may differ for each gene.
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Figure 8. Changes of histone modifications at the IL2 gene during T-cell
differentiation. The correlation between IL-2 expression and histone modifica-
tions from 4.6 through +0.25 kb of the IL2 gene is summarized.
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For example, in the activation of HNF-4a gene concomitant
with the enterocyte differentiation, diMeH3/K4 is restricted to
the promoter region through differentiation while acetylated
histones develop from the distal enhancer toward the promoter
(49) And at the IgH locus in pro B-cells, peaks of diMeH3/K4
are observed at the borders of active DJ regions and inactive V
and C regions (51). For immune regulatory cytokines, such as
IL-2, maintaining a transcriptionally permissive stage which is
marked by long-range diMeH3/K4 modification alone may be
important to preserve the potential for immediate gene activa-
tion in response to precisely calibrated external stimuli.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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